BNP PARIBAS FINANCIAL MARKETS - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$35,535
-69.2%
3,690
-71.2%
0.00%
Q2 2023$115,218
+23.0%
12,802
+7.4%
0.00%
Q1 2023$93,668
+126.8%
11,917
+95.1%
0.00%
Q4 2022$41,297
-100.0%
6,109
-15.7%
0.00%
Q3 2022$105,096,000
+79.3%
7,243
+21.6%
0.00%
Q2 2022$58,627,000
+124.8%
5,958
+236.8%
0.00%
Q1 2022$26,075,000
-58.7%
1,769
-62.9%
0.00%
Q4 2021$63,134,000
+0.5%
4,772
+32.6%
0.00%
Q3 2021$62,803,000
+241.3%
3,599
+368.6%
0.00%
Q2 2021$18,401,000
-91.4%
768
-90.8%
0.00%
Q1 2021$215,128,000
+283.1%
8,374
+183.2%
0.00%
Q4 2020$56,153,000
+26.1%
2,957
-16.4%
0.00%
Q3 2020$44,543,000
+220.7%
3,538
+208.2%
0.00%
Q2 2020$13,891,000
-60.6%
1,148
-75.1%
0.00%
Q1 2020$35,221,000
+9.8%
4,604
+155.6%
0.00%
Q4 2019$32,076,000
+87.6%
1,801
+22.2%
0.00%
Q3 2019$17,098,000
+1035.3%
1,474
+2067.6%
0.00%
Q2 2019$1,506,000680.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Prosight Management, LP 589,270$8,686,0005.61%
GREAT POINT PARTNERS LLC 874,197$12,886,0003.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 383,233$10,805,0002.44%
Frazier Life Sciences Management, L.P. 1,572,192$23,174,0001.98%
TANG CAPITAL MANAGEMENT LLC 648,269$9,555,0001.91%
Deep Track Capital, LP 1,729,757$25,497,0001.64%
Vivo Capital, LLC 1,533,559$22,605,0001.56%
Monashee Investment Management LLC 264,111$3,893,0001.13%
COMMODORE CAPITAL LP 312,553$4,607,0001.03%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,746,300$25,740,0000.79%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders